1031 related articles for article (PubMed ID: 21905663)
1. Acid-activatable prodrug nanogels for efficient intracellular doxorubicin release.
Zhan F; Chen W; Wang Z; Lu W; Cheng R; Deng C; Meng F; Liu H; Zhong Z
Biomacromolecules; 2011 Oct; 12(10):3612-20. PubMed ID: 21905663
[TBL] [Abstract][Full Text] [Related]
2. Endosomal pH-activatable poly(ethylene oxide)-graft-doxorubicin prodrugs: synthesis, drug release, and biodistribution in tumor-bearing mice.
Zhou L; Cheng R; Tao H; Ma S; Guo W; Meng F; Liu H; Liu Z; Zhong Z
Biomacromolecules; 2011 May; 12(5):1460-7. PubMed ID: 21332185
[TBL] [Abstract][Full Text] [Related]
3. Reduction-responsive disassemblable core-cross-linked micelles based on poly(ethylene glycol)-b-poly(N-2-hydroxypropyl methacrylamide)-lipoic acid conjugates for triggered intracellular anticancer drug release.
Wei R; Cheng L; Zheng M; Cheng R; Meng F; Deng C; Zhong Z
Biomacromolecules; 2012 Aug; 13(8):2429-38. PubMed ID: 22746534
[TBL] [Abstract][Full Text] [Related]
4. Acetal-linked paclitaxel prodrug micellar nanoparticles as a versatile and potent platform for cancer therapy.
Gu Y; Zhong Y; Meng F; Cheng R; Deng C; Zhong Z
Biomacromolecules; 2013 Aug; 14(8):2772-80. PubMed ID: 23777504
[TBL] [Abstract][Full Text] [Related]
5. Intracellular release of doxorubicin from core-crosslinked polypeptide micelles triggered by both pH and reduction conditions.
Wu L; Zou Y; Deng C; Cheng R; Meng F; Zhong Z
Biomaterials; 2013 Jul; 34(21):5262-72. PubMed ID: 23570719
[TBL] [Abstract][Full Text] [Related]
6. Core-crosslinked polymeric micelles with controlled release of covalently entrapped doxorubicin.
Talelli M; Iman M; Varkouhi AK; Rijcken CJ; Schiffelers RM; Etrych T; Ulbrich K; van Nostrum CF; Lammers T; Storm G; Hennink WE
Biomaterials; 2010 Oct; 31(30):7797-804. PubMed ID: 20673684
[TBL] [Abstract][Full Text] [Related]
7. In situ forming reduction-sensitive degradable nanogels for facile loading and triggered intracellular release of proteins.
Chen W; Zheng M; Meng F; Cheng R; Deng C; Feijen J; Zhong Z
Biomacromolecules; 2013 Apr; 14(4):1214-22. PubMed ID: 23477570
[TBL] [Abstract][Full Text] [Related]
8. Amphiphilic multi-arm-block copolymer conjugated with doxorubicin via pH-sensitive hydrazone bond for tumor-targeted drug delivery.
Prabaharan M; Grailer JJ; Pilla S; Steeber DA; Gong S
Biomaterials; 2009 Oct; 30(29):5757-66. PubMed ID: 19643472
[TBL] [Abstract][Full Text] [Related]
9. pH-sensitive degradable chimaeric polymersomes for the intracellular release of doxorubicin hydrochloride.
Du Y; Chen W; Zheng M; Meng F; Zhong Z
Biomaterials; 2012 Oct; 33(29):7291-9. PubMed ID: 22795540
[TBL] [Abstract][Full Text] [Related]
10. Redox and pH-responsive degradable micelles for dually activated intracellular anticancer drug release.
Chen W; Zhong P; Meng F; Cheng R; Deng C; Feijen J; Zhong Z
J Control Release; 2013 Aug; 169(3):171-9. PubMed ID: 23306022
[TBL] [Abstract][Full Text] [Related]
11. Shell-sheddable micelles based on dextran-SS-poly(epsilon-caprolactone) diblock copolymer for efficient intracellular release of doxorubicin.
Sun H; Guo B; Li X; Cheng R; Meng F; Liu H; Zhong Z
Biomacromolecules; 2010 Apr; 11(4):848-54. PubMed ID: 20205476
[TBL] [Abstract][Full Text] [Related]
12. Self-organized nanogels responding to tumor extracellular pH: pH-dependent drug release and in vitro cytotoxicity against MCF-7 cells.
Na K; Lee ES; Bae YH
Bioconjug Chem; 2007; 18(5):1568-74. PubMed ID: 17688320
[TBL] [Abstract][Full Text] [Related]
13. Stimuli-responsive PEGylated prodrugs for targeted doxorubicin delivery.
Xu M; Qian J; Liu X; Liu T; Wang H
Mater Sci Eng C Mater Biol Appl; 2015 May; 50():341-7. PubMed ID: 25746279
[TBL] [Abstract][Full Text] [Related]
14. Charge-conversional and reduction-sensitive poly(vinyl alcohol) nanogels for enhanced cell uptake and efficient intracellular doxorubicin release.
Chen W; Achazi K; Schade B; Haag R
J Control Release; 2015 May; 205():15-24. PubMed ID: 25445693
[TBL] [Abstract][Full Text] [Related]
15. Self-assemblies of pH-activatable PEGylated multiarm poly(lactic acid-co-glycolic acid)-doxorubicin prodrugs with improved long-term antitumor efficacies.
Ding J; Li D; Zhuang X; Chen X
Macromol Biosci; 2013 Oct; 13(10):1300-7. PubMed ID: 23852836
[TBL] [Abstract][Full Text] [Related]
16. Oxime linkage: a robust tool for the design of pH-sensitive polymeric drug carriers.
Jin Y; Song L; Su Y; Zhu L; Pang Y; Qiu F; Tong G; Yan D; Zhu B; Zhu X
Biomacromolecules; 2011 Oct; 12(10):3460-8. PubMed ID: 21863891
[TBL] [Abstract][Full Text] [Related]
17. Ketal cross-linked poly(ethylene glycol)-poly(amino acid)s copolymer micelles for efficient intracellular delivery of doxorubicin.
Lee SJ; Min KH; Lee HJ; Koo AN; Rim HP; Jeon BJ; Jeong SY; Heo JS; Lee SC
Biomacromolecules; 2011 Apr; 12(4):1224-33. PubMed ID: 21344942
[TBL] [Abstract][Full Text] [Related]
18. pH-Responsive chimaeric pepsomes based on asymmetric poly(ethylene glycol)-b-poly(l-leucine)-b-poly(l-glutamic acid) triblock copolymer for efficient loading and active intracellular delivery of doxorubicin hydrochloride.
Chen P; Qiu M; Deng C; Meng F; Zhang J; Cheng R; Zhong Z
Biomacromolecules; 2015 Apr; 16(4):1322-30. PubMed ID: 25759951
[TBL] [Abstract][Full Text] [Related]
19. pH and reduction dual-sensitive copolymeric micelles for intracellular doxorubicin delivery.
Chen J; Qiu X; Ouyang J; Kong J; Zhong W; Xing MM
Biomacromolecules; 2011 Oct; 12(10):3601-11. PubMed ID: 21853982
[TBL] [Abstract][Full Text] [Related]
20. Novel folated and non-folated pullulan bioconjugates for anticancer drug delivery.
Scomparin A; Salmaso S; Bersani S; Satchi-Fainaro R; Caliceti P
Eur J Pharm Sci; 2011 Apr; 42(5):547-58. PubMed ID: 21371555
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]